Interpretación del riesgo de diabetes tipo 1 mediante la genética y la epigenómica unicelular

Pérez B, Francisco; Cavada Ch, Gabriel.
Rev. chil. endocrinol. diabetes ; 14(3): 141-142, 2021. ilus
Artículo en Español | LILACS | ID: biblio-1293390

Documentos relacionados

  1. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics.
  2. Leveraging type 1 diabetes human genetic and genomic data in the T1D knowledge portal.
  3. TCR<sup>+</sup>/BCR<sup>+</sup> dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes.
  4. MHC-II heterozygosity limits type 1 diabetes susceptibility through negative selection.
  5. The Role of Epigenetics in Type 1 Diabetes.
  6. Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4<sup>+</sup> T cell perturbations.
  7. Th2 cell clonal expansion at diagnosis in human type 1 diabetes.
  8. High-throughput and high-dimensional single-cell analysis of antigen-specific CD8<sup>+</sup> T cells.
  9. Contribution of Retrotransposons to the Pathogenesis of Type 1 Diabetes and Challenges in Analysis Methods.
  10. Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the "omnigenic" sparse effector hypothesis of complex trait genetics.